Genetic engineering is the deliberate modification of an organism's genetic\nmaterial — usually its DNA — to introduce new traits, alter existing ones, or move\nspecific genetic content from one organism to another. It emerged in its modern\nform in the early 1970s, when the recombinant-DNA work of Paul Berg, Stanley\nCohen, and Herbert Boyer made it possible to cut, join, and copy genes at will,\nand it has since become the foundation of contemporary biotechnology. Its methods\nnow reach from routine laboratory cloning to the precise, programmable genome\nediting introduced by CRISPR-Cas9 in 2012.
\nFor the Wheel of Heaven framework, genetic engineering is\nmore than one science among many. The framework's account of the origin of\nterrestrial life — that the Elohim designed and assembled it in\nlaboratories, humanity included — is, in plain terms, a claim about genetic\nengineering carried out at a scale and sophistication far beyond the present state\nof the art. Contemporary biology, on this reading, is recovering a capability the\nElohim already possessed. This entry sets out the discipline as it actually\nstands before turning to that reading, and keeps the line clear between what the\nscience establishes and what the framework adds.
\nGenetic engineering rests on a handful of enabling discoveries and a toolkit of\nnatural enzymes repurposed for deliberate use. Its history is unusually\nwell-dated, and the reasons for pausing over its risks were built into the\ndiscipline from the start.
\nThrough the 1940s–1960s, molecular biology established the ground the discipline\nwould stand on: that DNA carries hereditary information (Avery, MacLeod, and\nMcCarty, 1944; Hershey and Chase, 1952), that it has a double-helix structure\n(Watson and Crick, 1953, built on Rosalind Franklin's X-ray diffraction data),\nand that its code could be read (the cracking of the genetic code, 1961–1966).\nWhat was still missing was any way to modify DNA deliberately.
\nThat capability arrived in 1972–1973. Paul Berg, at Stanford, produced the first\nrecombinant DNA molecule by splicing together DNA from two different sources.\nStanley Cohen (Stanford) and Herbert Boyer (UC San Francisco) then showed that\nsuch engineered DNA could be inserted into bacteria that would copy and express\nit — the Cohen-Boyer technique, still the practical foundation of the field.\nThe toolkit that made this work was assembled from natural molecules: restriction\nenzymes (Arber, Nathans, and Smith; Nobel Prize 1978) that cut DNA at defined\nsequences, DNA ligase to rejoin fragments, plasmids as vectors to carry genes\ninto cells, the polymerase chain reaction (Kary Mullis, 1983) to amplify DNA,\nand Sanger sequencing (Frederick Sanger, 1977) to read it back.
\nAs the technique spread, its practitioners paused over the hazards. In 1974 Berg\nand colleagues called for a voluntary moratorium on certain classes of experiment,\nand in February 1975 roughly 140 scientists met at the Asilomar Conference in\nCalifornia to set containment guidelines before proceeding. Asilomar is widely\nregarded as a rare instance of a research field confronting the risks of its own\nwork before harm occurred; it shaped the NIH recombinant-DNA guidelines (1976) and\nthe broader regulatory framework that followed. Commercial development moved\nquickly behind it — Genentech was founded in 1976, and recombinant human insulin\nreached patients in 1982.
\nThe field's second transformation came in 2012. CRISPR-Cas9, adapted from a\nbacterial immune system by Jennifer Doudna and Emmanuelle Charpentier,\ngave biologists a programmable way to cut DNA at almost any chosen sequence, using\na short guide RNA to steer the Cas9 enzyme to its target. Feng Zhang and George\nChurch demonstrated the following year that it worked in mammalian cells. Cheaper,\nfaster, and more precise than the earlier zinc-finger and TALEN methods, CRISPR\nbecame the dominant genome-editing platform within a few years; Doudna and\nCharpentier received the Nobel Prize in Chemistry in 2020, unusually soon after\nthe discovery.
\nRefinements followed. Base editing and prime editing (David Liu, 2016 and\n2019) make single-letter changes without cutting both DNA strands; variant systems\nsuch as Cas12 and Cas13 widen the range of targets. The first CRISPR therapy,\nCasgevy, was approved in late 2023 for sickle cell disease and\ntransfusion-dependent beta-thalassemia. These are genuine, current capabilities —\nbut they remain constrained. Off-target edits, incomplete editing that leaves\ncells with mixed genotypes, and immune responses to the editing machinery are all\nactive problems, and the long-term consequences of permanent genome changes are\nnot fully predictable.
\nGenetic engineering has branched into related fields, each treated in its own\nentry: synthetic biology (engineering biological systems\nfrom standardised parts), synthetic genomics (designing\nand synthesising whole genomes), and pantropy (engineering\norganisms for non-terrestrial environments); the life engineering\nentry treats the umbrella concept. The applications are already broad —\nrecombinant drugs and vaccines, including the mRNA COVID-19 vaccines; gene\ntherapies for inherited disease, and CAR-T treatments for cancer; genetically\nmodified crops; engineered enzymes, biofuels, and bioplastics. What the discipline\ncannot yet do is design a complex organism from scratch: it edits and recombines\nexisting life far more readily than it builds new life. That boundary matters for\nthe reading that follows.
\nThe framework's account of terrestrial life is, in the vocabulary of contemporary\nscience, a claim about genetic engineering — carried out long ago, by others, at a\nscale biology has not approached.
\nOn the reading developed from the Raëlian source material, life on\nEarth did not arise from unguided chemistry. It was designed and synthesised\nby the Elohim, an advanced civilization from a world outside the\nsolar system, who assembled terrestrial plants, animals, and finally humanity in\nlaboratories and released them into a prepared biosphere. The\nGenesis creation account is read as a compressed and partly garbled\nrecord of that project: the \"days\" of creation as ordered phases of engineering\nwork, and the making of humanity \"in our image\" — the plural Elohim speaking of\nthemselves — as the deliberate design of a species modelled on its makers.\nEden is read as the enclosed laboratory where the first human lineage\nwas synthesised, instructed, and observed. These are foundational claims of the\nframework, stated here as the corpus states them, and not endorsed by mainstream\nscience.
\nWhat the framework adds to contemporary biology is a claimed history and a named\nagent. Where directed panspermia — the 1973 hypothesis of Francis Crick and\nLeslie Orgel that life was deliberately seeded from elsewhere — leaves the seeding\ncivilization abstract, the corpus supplies the makers, the method (genetic design\nand laboratory synthesis), and a claimed contact record. The convergence in\nvocabulary is real: two of the leading molecular biologists of the twentieth\ncentury entertained the general shape of the claim. The framework does not pretend\nthey endorse its specifics. The point is narrower and worth stating carefully —\nscience has independently raised the general possibility of engineered life, even\nas it rejects the framework's particular account. The broader design question is\ndeveloped in the Intelligent design entry.
\nContemporary engineering as recovery. The framework reads today's genetic\nengineering as humanity recovering, on its own, the kind of capability the Elohim\nused at the creation. The double helix in 1953, recombinant DNA in the early\n1970s, and CRISPR in 2012 are read as milestones along that recovery. On the\ncorpus's chronology the acceleration belongs to the present transitional period —\nthe Apocalypse, coextensive with the\nAge of Aquarius — in which humanity approaches the\nthreshold of creating life itself. The Raëlian material, published in 1974–1976\njust as recombinant DNA was emerging, anticipates that humanity will one day make\nlife in laboratories as its makers did: the point at which, in the source's\nformulation, the created becomes a creator in turn. The relationship to the\nanticipated Great Return is read as preparation — current\ncapability is the ground on which the Elohim's far greater knowledge could build.\nThe name of the discipline preserves the connection the framework presses: genetic\nderives from the Greek génesis, \"origin, generation,\" the same word that titles\nthe creation account it reads as an engineering record.
\nThe withheld knowledge. The framework's reading of Genesis places engineering\nknowledge at the centre of the Eden story. The\nTree of the Knowledge of Good and Evil\nis read as the Elohim's own body of scientific knowledge, withheld from the first\nhumans by order of the home-world Council of the Eternals\nso that the creation would not become the creators' equal. The disclosure narrated\nin Genesis 3 — the serpent's counsel — is read as the act of the\nLucifer faction: a minority of the creators who judged the\ncontainment order unjust and gave their creation access to what it had been\ndenied, and who were exiled to Earth for it. The canon insists on keeping this\nfigure precise, because later tradition blurred it. The disclosing, preservationist\nfaction is Lucifer's, and it is distinct from Satan, who led a\nseparate faction holding that the whole human project was a mistake and should be\nabolished. The two are political opposites — Lucifer sought to empower humanity,\nSatan to end it — and the later Christian collapse of both into a single \"devil\"\nerases a real division within the creator civilization. On this reading, humanity's\npresent mastery of genetic engineering is the long completion of the knowledge\nLucifer's faction first began to hand over.
\nThe framework's creation claim is a minority position, and the distinction between\nit and the science whose vocabulary it borrows deserves to be stated plainly.\nMainstream biology treats the origin of life as an open but naturalistic question —\nabiogenesis on the early Earth, with no designer. That remains the more\nparsimonious hypothesis, because a designing civilization only relocates the origin\nproblem: the designers then need explaining in turn, and each such move adds an\nunobserved civilization without shrinking the mystery. There is no independent\nphysical evidence — no laboratory signature, no artefact, no confirmed contact —\nfor an engineered origin of terrestrial life. The corpus rests its case on a\nreading of ancient texts and a contact narrative that science does not accept as\ndata, and it does not claim otherwise. What it claims is narrower: that science has\nitself raised the general possibility of deliberate design, and that the framework\nstates its own commitments openly and keeps them distinct from what has been\ndemonstrated.
\nThe ethics of the real discipline are contested on their own terms, and the\nframework reads that debate as part of the same story of recovered capability.\nAsilomar set an early precedent for self-regulation. The 1999 death of Jesse\nGelsinger in a University of Pennsylvania gene-therapy trial — caused by a violent\nimmune reaction to the viral vector, amid inadequate consent and undisclosed\nconflicts of interest — set the field back by roughly a decade. The long public\nargument over genetically modified crops turns on environmental impact, corporate\nconcentration in the seed market, and consumer choice more than on any demonstrated\nhealth risk, which the scientific consensus has not found. The sharpest recent case\nis the He Jiankui affair: in November 2018 the Chinese biophysicist announced\nthe birth of twin girls whose embryos he had edited with CRISPR — without medical\nnecessity, adequate consent, or preclinical validation, and using forged ethical\nreview. He was imprisoned, and the episode hardened an international consensus\nagainst heritable human genome editing, which nearly all jurisdictions prohibit for\nclinical use. The framework reads this ethical engagement — the moratoria, the\nregulation, the self-correction — not as an obstacle but as evidence of a humanity\nlearning to hold a powerful capability responsibly, the disposition the source\nmaterial treats as the precondition for the larger inheritance the\nGreat Return anticipates.
\nThe real convergence between the framework and the science is narrow, and worth\nholding onto. Both take the origin and design of life to be a genuine, unsettled,\nand consequential question. They differ on whether it has already been answered —\nand on whether the answer is written in the genome or in the texts.
\nVorilhon, Claude (Raël). Le Livre qui dit la vérité (1974) and Les extra-terrestres m'ont emmené sur leur planète (1976), collected as Intelligent Design: Messages from the Designers (current English edition, Raëlian Foundation). [Primary source for the framework's reading of the Elohim's original genetic-engineering work and the broader contemporary recovery anticipation.]
\nBerg, Paul, David Baltimore, Sydney Brenner, Richard O. Roblin III, and Maxine F. Singer. \"Asilomar Conference on Recombinant DNA Molecules.\" Science 188, no. 4192 (June 6, 1975): 991–994. [The foundational publication of the Asilomar Conference recommendations.]
\nBerg, Paul. \"Asilomar 1975: DNA modification secured.\" Nature 455, no. 7211 (September 18, 2008): 290–291. [Berg's retrospective on the Asilomar Conference.]
\nCohen, Stanley N., Annie C. Y. Chang, Herbert W. Boyer, and Robert B. Helling. \"Construction of biologically functional bacterial plasmids in vitro.\" Proceedings of the National Academy of Sciences 70, no. 11 (November 1973): 3240–3244. [The foundational Cohen-Boyer publication establishing recombinant DNA technology.]
\nJinek, Martin, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A. Doudna, and Emmanuelle Charpentier. \"A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity.\" Science 337, no. 6096 (August 17, 2012): 816–821. [The foundational Doudna-Charpentier publication establishing CRISPR-Cas9 as a programmable genome-editing tool.]
\nCong, Le, F. Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D. Hsu, Xuebing Wu, Wenyan Jiang, Luciano A. Marraffini, and Feng Zhang. \"Multiplex genome engineering using CRISPR/Cas systems.\" Science 339, no. 6121 (February 15, 2013): 819–823. [The foundational Zhang publication establishing CRISPR-Cas9 for mammalian genome editing.]
\nDoudna, Jennifer A., and Samuel H. Sternberg. A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. Houghton Mifflin Harcourt, 2017. [The principal accessible scientific autobiography by one of the principal CRISPR developers.]
\nWatson, James D., and Andrew Berry. DNA: The Secret of Life. Knopf, 2003. [The principal accessible scientific history of molecular biology and genetic engineering.]
\nMukherjee, Siddhartha. The Gene: An Intimate History. Scribner, 2016. [The principal contemporary accessible history of genetics and genetic engineering.]
\nKrimsky, Sheldon. Genetic Alchemy: The Social History of the Recombinant DNA Controversy. MIT Press, 1982. [The principal scholarly history of the Asilomar-period controversies.]
\nWright, Susan. Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering, 1972-1982. University of Chicago Press, 1994. [The standard scholarly history of the early regulatory development.]
\nCarroll, Sean B. The Making of the Fittest: DNA and the Ultimate Forensic Record of Evolution. Norton, 2006.
\nVenter, J. Craig. Life at the Speed of Light: From the Double Helix to the Dawn of Digital Life. Viking, 2013.
\nChurch, George, and Ed Regis. Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves. Basic Books, 2012.
\nDavies, Kevin. Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing. Pegasus Books, 2020. [The principal contemporary scholarly history of the CRISPR era.]
\nKirksey, Eben. The Mutant Project: Inside the Global Race to Genetically Modify Humans. St. Martin's Press, 2020. [The principal scholarly engagement with the He Jiankui affair.]
\nNational Academies of Sciences, Engineering, and Medicine. Heritable Human Genome Editing. National Academies Press, 2020. [The principal contemporary international scientific community position on heritable genome editing.]
\nBiglino, Mauro. Il libro che cambierà per sempre le nostre idee sulla Bibbia. Mondadori, 2011. [Contemporary philological engagement with the Hebrew Bible's account of the Elohim's engineering work.]
\nSendy, Jean. La Lune, clé de la Bible. Julliard, 1968.
\nSendy, Jean. Ces dieux qui firent le ciel et la terre. Robert Laffont, 1969.
\nWallis, Paul. Escaping from Eden: Does Genesis Teach That the Human Race Was Created by God or Engineered by ETs? 6th Books, 2020.
\nDoudna, Jennifer A., and Emmanuelle Charpentier. \"The new frontier of genome engineering with CRISPR-Cas9.\" Science 346, no. 6213 (November 28, 2014): 1258096.
\nLander, Eric S. \"The Heroes of CRISPR.\" Cell 164, no. 1-2 (January 14, 2016): 18–28.
\nAnzalone, Andrew V., Peyton B. Randolph, Jessie R. Davis, Alexander A. Sousa, Luke W. Koblan, Jonathan M. Levy, Peter J. Chen, Christopher Wilson, Gregory A. Newby, Aditya Raguram, and David R. Liu. \"Search-and-replace genome editing without double-strand breaks or donor DNA.\" Nature 576 (December 2019): 149–157. [The foundational publication on prime editing.]
\n\"Genetic engineering.\" Wikipedia. https://en.wikipedia.org/wiki/Genetic_engineering
\n\"CRISPR.\" Wikipedia. https://en.wikipedia.org/wiki/CRISPR
\n\"Asilomar Conference on Recombinant DNA.\" Wikipedia. https://en.wikipedia.org/wiki/Asilomar_Conference_on_Recombinant_DNA
\n\"Recombinant DNA.\" Wikipedia. https://en.wikipedia.org/wiki/Recombinant_DNA
\n\"He Jiankui affair.\" Wikipedia. https://en.wikipedia.org/wiki/He_Jiankui_affair
\n\"Cartagena Protocol on Biosafety.\" Wikipedia. https://en.wikipedia.org/wiki/Cartagena_Protocol_on_Biosafety
\n", "extra": {"alternative_names":["Genetic modification","Gene splicing (historical informal usage)","Recombinant DNA technology (the foundational subdomain)","Genome editing (the contemporary CRISPR-era subdomain)"],"category":"Science & Technology","claim_type":"direct","editorial_pass":"2026-07","entry_type":"concept","infobox":{"contemporary_techniques":"CRISPR-Cas9 (genome editing, 2012 onward); CRISPR-Cas12, CRISPR-Cas13 (variant systems); base editing; prime editing; TALENs (transcription activator-like effector nucleases); zinc finger nucleases; gene drives; mRNA technology (developed rapidly during the COVID-19 vaccine response)","foundational_figures":"Paul Berg (Stanford, recombinant DNA, Nobel Prize 1980); Stanley Cohen (Stanford) and Herbert Boyer (UCSF) (Cohen-Boyer technique, 1973); Werner Arber, Daniel Nathans, Hamilton Smith (restriction enzymes, Nobel Prize 1978); Frederick Sanger (DNA sequencing, second Nobel Prize 1980); Kary Mullis (PCR, Nobel Prize 1993); Jennifer Doudna and Emmanuelle Charpentier (CRISPR-Cas9, Nobel Prize 2020)","foundational_period":"Early 1970s — Paul Berg's first recombinant DNA molecule (1972); Stanley Cohen and Herbert Boyer's first successful bacterial transformation with recombinant DNA (1973); the Asilomar Conference (February 1975)","foundational_techniques":"Restriction enzymes; DNA ligase; plasmids as vectors; bacterial transformation; polymerase chain reaction (PCR); DNA sequencing (Sanger method, subsequent next-generation sequencing); gel electrophoresis","framework_significance":"Read by the framework as humanity's recovery of the engineering capability the Elohim used to synthesize terrestrial life; the acceleration of that capability is read as a marker of the Apocalypse-age transition","major_applications":"Medical (recombinant insulin from 1978, recombinant therapeutic proteins, gene therapy, CAR-T cell therapy, mRNA vaccines); agricultural (Bt crops, Roundup-Ready crops, Golden Rice, the broader GMO industry); industrial (bioplastics, biofuels, recombinant enzymes); research (model organisms, knockout/knock-in studies, cellular reprogramming)","regulatory_framework":"NIH Guidelines for Research Involving Recombinant DNA Molecules (1976, regularly updated); USDA, FDA, EPA regulatory authority (US); the more restrictive EU framework; Cartagena Protocol on Biosafety (2003); national variations across most jurisdictions; the contested status of heritable human genome editing","related_disciplines":"Synthetic biology; synthetic genomics; pantropy; life engineering (the broader umbrella concept); cell biology; molecular biology; biochemistry; bioinformatics; structural biology","type":"The scientific discipline of deliberately modifying an organism's genetic material to introduce, alter, or transfer genetic content"},"lang":"en","lang_prefix":"","same_as":["https://www.wikidata.org/wiki/Q159236","https://en.wikipedia.org/wiki/Genetic_engineering","https://www.britannica.com/science/genetic-engineering"],"see_also":[{"description":"The umbrella concept organizing genetic engineering and its sister disciplines within the framework.","path":"wiki/life-engineering","title":"Life engineering"},{"description":"The engineering-discipline field that overlaps and extends genetic engineering.","path":"wiki/synthetic-biology","title":"Synthetic biology"},{"description":"The genome-scale design and synthesis field spawned from genetic engineering.","path":"wiki/synthetic-genomics","title":"Synthetic genomics"},{"description":"The engineering of organisms for non-terrestrial environments, a related descendant discipline.","path":"wiki/pantropy","title":"Pantropy"},{"description":"The anticipated knowledge transfer that the framework reads current engineering capability as preparing for.","path":"wiki/great-return","title":"Great Return"},{"description":"The civilization whose original synthesis capability the framework reads humanity as recovering.","path":"wiki/elohim","title":"Elohim"}],"timeline":["aquarius"]} }, "links": { "self": "/v1/wiki/genetic-engineering/", "canonical_html": "https://www.wheelofheaven.world/wiki/genetic-engineering/", "index": "/v1/wiki/", "schema": "/v1/schema/wiki-entry/", "related": [{"slug": "life-engineering", "title": "Life engineering", "kind": "WikiEntry", "type": "see_also", "url": "/v1/wiki/life-engineering/" },{"slug": "synthetic-biology", "title": "Synthetic biology", "kind": "WikiEntry", "type": "see_also", "url": "/v1/wiki/synthetic-biology/" },{"slug": "synthetic-genomics", "title": "Synthetic genomics", "kind": "WikiEntry", "type": "see_also", "url": "/v1/wiki/synthetic-genomics/" },{"slug": "pantropy", "title": "Pantropy", "kind": "WikiEntry", "type": "see_also", "url": "/v1/wiki/pantropy/" },{"slug": "great-return", "title": "Great Return", "kind": "WikiEntry", "type": "see_also", "url": "/v1/wiki/great-return/" },{"slug": "elohim", "title": "Elohim", "kind": "WikiEntry", "type": "see_also", "url": "/v1/wiki/elohim/" }] } }